SleepSpecialty appeals · Sleep medicine

Sleep medicine denials: appealing sleep-study and PAP denials

Sleep-medicine denials split in two: the plan wanting a home test where an in-lab study is indicated, and PAP therapy denied or cut off for adherence documentation. Both are answerable with the clinical indication and the device data.

Denials in sleep medicine fall into two recurring patterns: a plan steering an in-lab polysomnogram to a home sleep apnea test (or denying the in-lab study), and PAP-therapy denials — initial device, titration, or re-supply — that turn on documented adherence. The appeal restores the clinical indication for the test setting, or supplies the adherence and benefit documentation the policy requires.

Why these denials happen

Plans default to home sleep apnea testing for uncomplicated suspected obstructive sleep apnea and require a documented indication for in-lab polysomnography (comorbidities, suspected non-OSA disorders, or a failed/inconclusive home test). PAP coverage is conditioned on a qualifying study and, for continued coverage and re-supply, on adherence data meeting the policy threshold and documented benefit. AASM standards and Medicare LCDs are the reference points; the denial flags the missing indication or the adherence gap.

The common denials

  • In-lab polysomnography denied in favor of a home sleep apnea test.
  • Home test result deemed insufficient to qualify the diagnosis or PAP.
  • PAP device denied — qualifying study or AHI threshold not documented.
  • Continued PAP or re-supply denied — adherence data below the policy threshold.
  • Procedure or device not matched to the plan's or the LCD's criteria.

Is it worth appealing?

Sometimes worth appealing

Worth appealing when the indication or the adherence data supports it: for an in-lab study, document the comorbidities or suspected non-OSA disorder that make a home test inappropriate; for PAP, supply the qualifying study and the adherence and benefit data the policy requires. A denial that simply reflects genuinely missing adherence is better solved by capturing the data than by appealing.

How to appeal

  1. 1

    Justify the test setting

    For an in-lab study, document the comorbidities, suspected non-OSA disorder, or failed home test that make in-lab polysomnography the indicated test under AASM standards.

  2. 2

    Supply the PAP qualifying criteria

    Document the qualifying study and the AHI threshold the policy requires for the device.

  3. 3

    Document adherence and benefit

    For continued coverage or re-supply, attach the adherence data meeting the policy threshold and the documented clinical benefit.

Frequently asked

The plan wants a home test, but my doctor ordered an in-lab study.
Document the comorbidities or suspected non-OSA disorder that make a home test inappropriate under AASM standards, and appeal the in-lab study on that indication.
My PAP re-supply was denied for adherence — can I appeal?
If the adherence data meets the policy threshold and benefit is documented, attach both and appeal. If adherence is genuinely below threshold, capturing compliant data is usually the faster path.

Clinical-coverage patterns and guideline references are summarized for plain-language reference and vary by plan and payer policy. This is general information for clinicians and billing staff, not medical, legal, or coding advice — confirm against the governing coverage policy and the current guideline for each claim.

When the appeal has to be written, and cited

Upload the denied EOB and Merits returns a complete, citation-verified appeal letter — the clinical argument, the payer's own coverage criteria, and your federal appeal rights — in about a minute.